A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: Part 1

Alternative Medicine Review

Volumn 15, Issue 3, 2010, Pages 245-263

  Kelly, Greg ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID; POLYPHENOL DERIVATIVE; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN; SIRTUIN;

ALCOHOL CONSUMPTION; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DIET; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EPIGENETICS; EXERCISE; FATTY LIVER; HUMAN; LIFESTYLE; LONGEVITY; MAMMAL; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

AGING; BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; ENZYME ACTIVATORS; HUMANS; LEARNING; LONGEVITY; MEMORY; NEOPLASMS; NERVOUS SYSTEM DISEASES; OBESITY; PHENOLS; SIRTUINS; STILBENES;

EID: 77957975705     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (186)

1. Vinciguerra M, Fulco M, Ladurner A, et al. SIRT1 in muscle physiology and disease: lessons from mouse models. Dis Model Mech 2010;3:298-303.
2. Michishita E, Park JY, Burneskis JM, et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005;16:4623-4635. (Pubitemid 41416446)
3. Tennen RI, Berber E, Chua KF. Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev 2010;131:185-192.
4. Shan T, Wang Y, Wu T, et al. Porcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol. J Anim Sci 2009;87:895-904.
5. Harting K, Knöll B. SIRT2-mediated protein deacetylation: an emerging key regulator in brain physiology and pathology. Eur J Cell Biol 2010;89:262-269.
6. Jing E, Gesta S, Kahn CR. SIRT2 regulates adipocyte differentiation through FOXO1 acetylation/deacetylation. Cell Metab 2007;6:105-114.
7. Luthi-Carter R, Taylor DM, Pallos J, et al. SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci U S A 2010;107:7927-7932.
8. Southwood CM, Peppi M, Dryden S, et al. Microtubule deacetylases, SIRT2 and HDAC6, in the nervous system. Neurochem Res 2007;32:187-195. (Pubitemid 46238864)
9. Wang F, Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol Biol Cell 2009;20:801-808.
10. Huang JY, Hirschey MD, Shimazu T, et al. Mitochondrial sirtuins. Biochim Biophys Acta 2010;1804:1645-1651.
11. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007;404:1-13. (Pubitemid 46788079)
12. Hokari F, Kawasaki E, Sakai A, et al. Muscle contractile activity regulates SIRT3 protein expression in rat skeletal muscles. J Appl Physiol 2010;109:332-340.
13. Haigis MC, Guarente LP. Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006;20:2913-2921.
14. Sundaresan NR, Samant SA, Pillai VB, et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 2008;28:6384-6401.
15. Ahuja N, Schwer B, Carobbio S, et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 2007;282:33583-33592. (Pubitemid 350159524)
16. Ogura M, Nakamura Y, Tanaka D, et al. Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem Biophys Res Commun 2010;393:73-78.
17. Kanfi Y, Peshti V, Gil R, et al. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 2010;9:162-173.
18. Koltai E, Szabo Z, Atalay M, et al. Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech Ageing Dev 2010;131:21-28.
19. Liszt G, Ford E, Kurtev M, Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 2005;280:21313-21320. (Pubitemid 40805693)
20. Ford E, Voit R, Liszt G, et al. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 2006;20:1075-1080.
21. Vakhrusheva O, Smolka C, Gajawada P, et al. SIRT7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 2008;102:703-710. (Pubitemid 351457857)
22. Kong XX, Wang R, Liu XJ, et al. Function of SIRT1 in physiology. Biochemistry (Mosc) 2009;74:703-708.
23. Sauve AA. Sirtuin chemical mechanisms. Biochim Biophys Acta 2010;1804;1591-1603.
24. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004;73:417-435.
25. North BJ, Verdin E. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol 2004;5:224.
26. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur J Biochem 2000;267:1550-1564.
27. Weyrich P, Machicao F, Reinhardt J, et al. SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention - the TULIP Study. BMC Med Genet 2008;9:100.
28. Peeters AV, Beckers S, Verrijken A, et al. Association of SIRT1 gene variation with visceral obesity. Hum Genet 2008;124:431-436.
29. Zillikens MC, van Meurs JB, Rivadeneira F, et al. SIRT1 genetic variation is related to BMI and risk of obesity. Diabetes 2009;58:2828-2834.
30. Zillikens MC, van Meurs JB, Sijbrands EJ, et al. SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin. Free Radic Biol Med 2009;46:836-841.
31. Kuningas M, Putters M, Westendorp RG, et al. SIRT1 gene, age-related diseases, and mortality: the Leiden 85-plus study. J Gerontol A Biol Sci Med Sci 2007;62:960-965.
32. Flachsbart F, Croucher PJ, Nikolaus S, et al. Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional human longevity. Exp Gerontol 2006;41:98-102.
33. Rose G, Dato S, Altomare K, et al. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 2003;38:1065-1070.
34. Reiling E, van Vliet-Ostaptchouk JV, van 't Riet E, et al. Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE study. Eur J Hum Genet 2009;17:1056-1062.
35. Bamps S, Wirtz J, Savory FR, et al. The Caenorhabditis elegans sirtuin gene, sir-2.1, is widely expressed and induced upon caloric restriction. Mech Ageing Dev 2009;130:762-770.
36. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004;305:390-392. (Pubitemid 38938153)
37. Greer EL, Brunet A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 2009;8:113-127.
38. + metabolism and calorie restriction. Biochim Biophys Acta 2010;1804:1567-1575.
39. Boily G, Seifert EL, Bevilacqua L, et al. SIRT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008;3:e1759.
40. Estep PW 3rd, Warner JB, Bulyk ML. Short-term calorie restriction in male mice feminizes gene expression and alters key regulators of conserved aging regulatory pathways. PLoS One 2009;4:e5242.
41. Allard JS, Heilbronn LK, Smith C, et al. In vitro cellular adaptations of indicators of longevity in response to treatment with serum collected from humans on calorie restricted diets. PLoS One 2008;3:e3211.
42. Civitarese AE, Carling S, Heilbronn LK, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 2007;4:e76.
43. Crujeiras AB, Parra D, Goyenechea E, Martinez JA. Sirtuin gene expression in human mononuclear cells is modulated by caloric restriction. Eur J Clin Invest 2008;38:672-678.
44. Capel F, Viguerie N, Vega N, et al. Contribution of energy restriction and macronutrient composition to changes in adipose tissue gene expression during dietary weight-loss programs in obese women. J Clin Endocrinol Metab 2008;93:4315-4322.
45. Firestein R, Blander G, Michan S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008;3:e2020.
46. Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 2007;26:1913-1923. (Pubitemid 46624046)
47. Kume S, Uzu T, Horiike K, et al. Calorie restriction enhances cell adaptation to hypoxia through SIRT1-dependent mitochondrial autophagy in mouse aged kidney. J Clin Invest 2010;120:1043-1055.
48. Picard F, Kurtev M, Chung N, et al. SIRT1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004;429:771-776. (Pubitemid 38833129)
49. Hirschey MD, Shimazu T, Goetzman E, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010;464:121-125.
50. Palados OM, Carmona JJ, Michan S, et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY) 2009;1:771-783.
51. Shi T, Fan GQ, Xiao SD. SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J Dig Dis 2010;11:55-62.
52. Shimazu T, Hirschey MD, Huang JY, et al. Acetate metabolism and aging: an emerging connection. Mech Ageing Dev 2010 May 15. [Epub ahead of print]
53. Nakagawa T, Guarente L. Urea cycle regulation by mitochondrial sirtuin, SIRT5. Aging (Albany NY) 2009;1:578-581.
54. Erion DM, Yonemitsu S, Nie Y, et al. SIRT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. Proc Natl Acad Sci U S A 2009;106:11288-11293.
55. Nie Y, Erion DM, Yuan Z, et al. STAT3 inhibition of gluconeogenesis is downregulated by SIRT1. Nat Cell Biol 2009;11:492-500.
56. Purushotham A, Schug TT, Xu Q, et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009;9:327-338.
57. Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-118. (Pubitemid 40349395)
58. Rodgers JT, Puigserver P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci U S A 2007;104:12861-12866. (Pubitemid 47255245)
59. Ramadori G, Lee CE, Bookout AL, et al. Brain SIRT1: anatomical distribution and regulation by energy availability. J Neurosci 2008;28:9989-9996.
60. Cakir I, Perello M, Lansari O, et al. Hypothalamic SIRT1 regulates food intake in a rodent model system. PLoS One 2009;4:e8322.
61. Chen D, Steele AD, Lindquist S, Guarente L. Increase in activity during calorie restriction requires Sirt1. Science 2005;310:1641.
62. Suwa M, Nakano H, Radak Z, Kumagai S. Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor gamma coactivator-1alpha protein expressions in rat skeletal muscle. Metabolism 2008;57:986-998.
63. Chabi B, Adhihetty PJ, O'Leary MF, et al. Relationship between SIRT1 expression and mitochondrial proteins during conditions of chronic muscle use and disuse. J Appl Physiol 2009;107:1730-1735.
64. Ferrara N, Rinaldi B, Corbi G, et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 2008;11:139-150. (Pubitemid 351271626)
65. Dumke CL, Mark Davis J, Angela Murphy E, et al. Successive bouts of cycling stimulates genes associated with mitochondrial biogenesis. Eur J Appl Physiol 2009;107:419-427.
66. Marfe G, Tafani M, Pucci B, et al. The effect of marathon on mRNA expression of anti-apoptotic and pro-apoptotic proteins and sirtuins family in male recreational long-distance runners. BMC Physiol 2010;10:7.
67. Lanza IR, Short DK, Short KR, et al. Endurance exercise as a countermeasure for aging. Diabetes 2008;57:2933-2942.
68. Oliva J, French BA, Li J, et al. SIRT1 is involved in energy metabolism: the role of chronic ethanol feeding and resveratrol. Exp Mol Pathol 2008;85:155-159.
69. Ajmo JM, Liang X, Rogers CQ, et al. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008;295:G833-G842.
70. Lieber CS, Leo MA, Wang X, Decarli LM. Effect of chronic alcohol consumption on hepatic SIRT1 and PGC-1alpha in rats. Biochem Biophys Res Commun 2008;370:44-48.
71. Scalera F, Fulge B, Martens-Lobenhoffer J, et al. Red wine decreases asymmetric dimethylarginine via SIRT1 induction in human endothelial cells. Biochem Biophys Res Commun 2009;390:703-709.
72. Mukherjee S, Lekli I, Gurusamy N, et al. Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med 2009;46:573-578.
73. Napoli C, Balestrieri ML, Sica V, et al. Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis. Heart Vessels 2008;23:124-133. (Pubitemid 351494092)
74. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:861-870.
75. Yang SR, Wright J, Bauter M, et al. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007;292:L567-L576.
76. Caito S, Rajendrasozhan S, Cook S, et al. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J 2010 Apr 12. [Epub ahead of print]
77. Arunachalam G, Yao H, Sundar IK, et al. SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochem Biophys Res Commun 2010;393:66-72.
78. Bai L, Pang WJ, Yang YJ, Yang GS. Modulation of SIRT1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 2008;307:129-140. (Pubitemid 350238655)
79. Breen DM, Sanli T, Giacca A, Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochem Biophys Res Commun 2008;374:117-122.
80. Wang GL, Fu YC, Xu WC, et al. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via SIRT1-FOXO1 signaling pathway. Biochem Biophys Res Commun 2009;380:644-649.
81. Lee JH, Song MY, Song EK, et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009;58:344-351.
82. He W, Wang Y, Zhang MZ, et al. SIRT1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 2010;120:1056-1068.
83. Chen CJ, Yu W, Fu YC, et al. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FOXO1 pathway. Biochem Biophys Res Commun 2009;378:389-393.
84. Grada-Sancho J, Villarreal G Jr, Zhang Y, García-Cardeña G. Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. Cardiovasc Res 2010;85:514-519.
85. Miyazaki R, Ichiki T, Hashimoto T, et al. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2008;28:1263-1269.
86. Chong ZZ, Maiese K. Enhanced tolerance against early and late apoptotic oxidative stress in mammalian neurons through nicotinamidase and sirtuin mediated pathways. Curr Neurovasc Res 2008;5:159-170.
87. Raval AP, Dave KR, Pérez-Pinzón MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2006;26:1141-1147.
88. Boily G, He XH, Pearce B, et al. SIRT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 2009;28:2882-2893.
89. Blander G, Bhimavarapu A, Mammone T, et al. SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol 2009;129:41-49.
90. Bäckesjo CM, Li Y, Lindgren U, Haldosén LA. Activation of SIRT1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 2006;21:993-1002. (Pubitemid 43962828)
91. Yu W, Fu YC, Zhou XH, et al. Effects of resveratrol on H(2)O(2)-induced apoptosis and expression of SIRTs in H9c2 cells. J Cell Biochem 2009;107:741-747.
92. Tang BL. Resveratrol is neuroprotective because it is not a direct activator of SIRT1 - a hypothesis. Brain Res Bull 2010;81:359-361.
93. Um JH, Park SJ, Rang H, et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010;59:554-563.
94. Fröjdö S, Durand C, Pirola L. Metabolic effects of resveratrol in mammals - a link between improved insulin action and aging. Curr Aging Sci 2008;1:145-151.
95. Zhang J. Resveratrol inhibits insulin responses in a SIRT1-independent pathway. Biochem J 2006;397:519-527.
96. Davis JM, Murphy EA, Carmichael MD, Davis B. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 2009;296:R1071-R1077.
97. Nieman DC, Williams AS, Shanely RA, et al. Quercetin's influence on exercise performance and muscle mitochondrial biogenesis. Med Sci Sports Exerc 2010;42:338-345.
98. Lee YA, Cho EJ, Yokozawa T. Protective effect of persimmon (Diospyros kaki) peel proanthocyanidin against oxidative damage under H2O2-induced cellular senescence. Biol Pharm Bull 2008;31:1265-1269.
99. Yokozawa T, Lee YA, Zhao Q, et al. Persimmon oligomeric proanthocyanidins extend life span of senescence-accelerated mice. J Med Food 2009;12:1199-1205.
100. Amat R, Solanes G, Giralt M, Villarroya F. SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription. J Biol Chem 2007;282:34066-34076. (Pubitemid 350159429)
101. Asher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008;134:317-328. (Pubitemid 352024391)
102. Belden WJ, Dunlap JC. SIRT1 is a circadian deacetylase for core clock components. Cell 2008;134:212-214. (Pubitemid 352010342)
103. Borradaile NM, Pickering JG. NAD(+), sirtuins, and cardiovascular disease. Curr Pharm Des 2009;15:110-117.
104. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-2015.
105. Chaudhary N, Pfluger PT. Metabolic benefits from SIRT1 and SIRT1 activators. Curr Opin Clin Nutr Metab Care 2009;12:431-437.
106. Fu M, Liu M, Sauve AA, et al. Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol 2006;26:8122-8135.
107. Rajamohan SB, Pillai VB, Gupta M, et al. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol 2009;29:4116-4129.
108. Takata T, Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem Biophys Res Commun 2003;301:250-257.
109. Tang BL, Chua CE. Is systemic activation of SIRT1 beneficial for ageing-associated metabolic disorders? Biochem Biophys Res Commun 2010;391:6-10.
110. Yamamori T, DeRicco J, Naqvi A, et al. SIRT1 deacetylates APE1 and regulates cellular base excision repair. Nucleic Acids Res 2010;38:832-845.
111. Yao Y, Li H, Gu Y, et al. Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling. Carcinogenesis 2010;31:382-387.
112. You M, Liang X, Ajmo JM, Ness GC. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 2008;294:G892-G898.
113. You M, Cao Q, Liang X, et al. Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice. J Nutr 2008;138:497-501.
114. Bae NS, Swanson MJ, Vassilev A, Howard BH. Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10. J Biochem 2004;135:695-700.
115. Black JC, Mosley A, Kitada T, et al. The SIRT2 deacetylase regulates autoacetylation of p300. Mol Cell 2008;32:449-455.
116. Inoue T, Nakayama Y, Yamada H, et al. SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest. Cell Cycle 2009;8:1279-1291.
117. Inoue T, Hiratsuka M, Osaki M, Oshimura M. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 2007;6:1011-1018.
118. Jin YH, Kim YJ, Kim DW, et al. SIRT2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem Biophys Res Commun 2008;368:690-695.
119. Li W, Zhang B, Tang J, et al. Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J Neurosci 2007;27:2606-2616.
120. Peck B, Chen CY, Ho KK, et al. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther 2010;9:844-855.
121. Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 2006;103:10230-10235.
122. Li S, Banck M, Mujtaba S, et al. p53-Induced growth arrest is regulated by the mitochondrial SIRT3 deacetylase. PLoS One 2010;5:e10486.
123. Schlicker C, Gertz M, Papatheodorou P, et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins SIRT3 and SIRT5. J Mol Biol 2008;382:790-801.
124. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005;280:13560-13567.
125. Sundaresan NR, Gupta M, Kim G, et al. SIRT3 blocks the cardiac hypertrophic response by augmenting FOXO3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009;119:2758-2771.
126. +-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J Biol Chem 2010;285:7417-7429.
127. McCord RA, Michishita E, Hong T, et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) 2009;1:109-121.
128. Van Gool F, Gallí M, Gueydan C, et al. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 2009;15:206-210.
129. Haigis MC, Mostoslavsky R, Haigis KM, et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006;126:941-954.
130. Alcaín FJ, Villalba JM. Sirtuin activators. Expert Opin Ther Pat 2009;19:403-414.
131. Balestrieri ML, Rienzo M, Felice F, et al. High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim Biophys Acta 2008;1784:936-945.
132. Bordone L, Motta MC, Picard F, et al. SIRT1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 2006;4:e31.
133. Hisahara S, Chiba S, Matsumoto H, Horio Y. Transcriptional regulation of neuronal genes and its effect on neural functions: NAD-dependent histone deacetylase SIRT1 (Sir2alpha). J Pharmacol Sci 2005;98:200-204
134. Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001;107:137-148.
135. Vaziri H, Dessain SK, Ng Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001;107:149-159.
136. Yang Y, Hou H, Haller EM, et al. Suppression of FOXO1 activity by FHL2 through SIRTl-mediated deacetylation. EMBOJ 2005;24:1021-1032.
137. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008;134:329-340.
138. + salvage pathway by CLOCK-SIRT1. Science 2009;324:654-657.
139. + biosynthesis. Science 2009;324:651-654.
140. Escande C, Chini CC, Nin V, et al. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J Clin Invest 2010;120:545-558.
141. Han Y, Jin YH, Kim YJ, et al. Acetylation of SIRT2 by p300 attenuates its deacetylase activity. Biochem Biophys Res Commun 2008;375:576-580.
142. Nedachi T, Kadotani A, Ariga M, et al. Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FOXO3a in C2C12 myocytes. Am J Physiol Endocrinol Metab 2008;294:E668-E678.
143. Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007;6:307-319.
144. Sasaki T, Maier B, Koclega KD, et al. Phosphorylation regulates SIRT1 function. PLoS One 2008;3:e4020.
145. Nasrin N, Kaushik VK, Fortier E, et al. JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS One 2009;4:e8414.
146. 3 and sirtuin function. Trends Biochem Sci 2005;30:479-483.
147. Imai S. The NAD World: a new systemic regulatory network for metabolism and aging - SIRT1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 2009;53:65-74.
148. Avalos JL, Bever KM, Wolberger C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 2005;17:855-868.
149. Prusty D, Mehra P, Srivastava S, et al. Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth. FEMS Microbiol Lett 2008;282:266-272. (Pubitemid 351569465)
150. Bitterman KJ, Anderson RM, Cohen HY, et al. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 2002;277:45099-45107.
151. + levels and SIRT inhibition. Exp Hematol 2009;37:1340-1352.e3.
152. Sauve AA, Moir RD, Schramm VL, Willis IM. Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol Cell 2005;17:595-601.
153. Schmidt MT, Smith BC, Jackson MD, Denu JM. Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulation. J Biol Chem 2004;279:40122-40129.
154. + consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med 2009;11:28-42.
155. Khan JA, Forouhar F, Tao X, Tong L. Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery. Expert Opin Ther Targets 2007;11:695-705. (Pubitemid 46730083)
156. + metabolism in health and disease. Trends Biochem Sci 2007;32:12-19.
157. +. PLoS Biol 2007;5:e263.
158. Yang T, Sauve AA. NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J 2006;8:E632-E643.
159. + homeostasis in man. Cell Mol Life Sci 2004;61:19-34.
160. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by NAMPT/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007;23:164-170.
161. Rongvaux A, Andris F, Van Gool F, Leo O. Reconstructing eukaryotic NAD metabolism. Bioessays 2003;25:683-690.
162. Stern RH, Freeman D, Spence JD. Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action? Metabolism 1992;41:879-881.
163. Fukuwatari T, Wada H, Sasaki R, Shibata K. Effects of excess nicotinamide administration on the urinary excretion of nicotinamide N-oxide and nicotinuric acid by rats. Biosci Biotechnol Biochem 2004;68:44-50. (Pubitemid 39251562)
164. Zhou SS, Li D, Sun WP, et al. Nicotinamide overload may play a role in the development of type 2 diabetes. World J Gastroenterol 2009;15:5674-5684.
165. 3: from metabolism to therapies. J Pharmacol Exp Ther 2008;324:883-893.
166. Collins PB, Chaykin S. The management of nicotinamide and nicotinic acid in the mouse. J Biol Chem 1972;247:778-783.
167. + and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats. J Nutr 1995;125:1455-1461.
168. + metabolism. J Biol Chem 2009;284:158-164.
169. + in fungi and humans. Cell 2004;117:495-502. (Pubitemid 38610234)
170. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and Sir2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000;289:2126-2128.
171. Anderson RM, Bitterman KJ, Wood JG, et al. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 2003;423:181-185.
172. Fukuwatari T, Shibata K, Ishihara K, et al. Elevation of blood NAD level after moderate exercise in young women and mice. J Nutr Sci Vitaminol (Tokyo) 2001;47:177-179. (Pubitemid 32578280)
173. Borradaile NM, Pickering JG. Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment. Aging Cell 2009;8:100-112.
174. Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of NAMPT. Dev Cell 2008;14:661-673. (Pubitemid 351622608)
175. + salvage pathway is enhanced. FEBS Lett 2009;583:3081-3085.
176. Yang H, Yang T, Baur JA, et al. Nutrient-sensitive mitochondrial NAD* levels dictate cell survival. Cell 2007;130:1095-1107. (Pubitemid 47410271)
177. Lu SP, Kato M, Lin SJ. Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae. J Biol Chem 2009;284:17110-17119.
178. Revollo JR, Körner A, Mills KF, et al. NAMPT/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007;6:363-375.
179. Chong ZZ, Lin SH, Li F, Maiese K. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways. Curr Neurovasc Res 2005;2:271-285.
180. Gallo CM, Smith DL Jr, Smith JS. Nicotinamide clearance by Pnc1 directly regulates Sir2-mediated silencing and longevity. Mol Cell Biol 2004;24:1301-1312.
181. Green KN, Steffan JS, Martinez-Coria H, et al. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 2008;28:11500-11510.
182. Sandmeier JJ, Celic I, Boeke JD, Smith JS. Telomeric and rDNA silencing in Saccharomyces cerevisiae are dependent on a nuclear NAD(+) salvage pathway. Genetics 2002;160:877-889. (Pubitemid 34263455)
183. Hara N, Yamada K, Shibata T, et al. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J Biol Chem 2007;282:24574-24582.
184. Hageman GJ, Stierum RH, van Herwijnen MH, et al. Nicotinic acid supplementation: effects on niacin status, cytogenetic damage, and poly(ADP-ribosylation) in lymphocytes of smokers. Nutr Cancer 1998;32:113-120.
185. + synthesis. Cell 2007;129:453-454.
186. Yang T, Chan NY, Sauve AA. Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J Med Chem 2007;50:6458-6461. (Pubitemid 350309084)